Qian, Kewen
108  Ergebnisse:
Personensuche X
?
6

EGFR/JIP-4/JNK2 signaling attenuates cetuximab-mediated rad..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Qian, Kewen ; Li, Tian ; Fu, Wenyan.. - p. 151-154 , 2023
 
?
7

Overcoming acquired resistance to EGFR-targeted therapy by ..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Qian, Kewen ; Fu, Wenyan ; Hu, Shi - p. 173-177 , 2023
 
?
8

Dual inhibition of EGFR and c-Src by cetuximab and dasatini..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Qian, Kewen ; Fu, Wenyan ; Lei, Changhai. - p. 99-103 , 2023
 
?
10

Contributors:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
 
?
11

Overcoming acquired resistance to cetuximab by combining EG..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Qian, Kewen ; Lei, Changhai ; Hu, Shi - p. 63-67 , 2023
 
?
12

Novel Toll-like receptor 9 agonist induces epidermal growth..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Qian, Kewen ; Lei, Changhai ; Hu, Shi - p. 185-188 , 2023
 
?
13

CT16: A dual antibody targeting both EGFR and Notch suppres..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Qian, Kewen ; Lei, Changhai ; Hu, Shi - p. 83-89 , 2023
 
?
15

The roles of small extracellular vesicles in cancer and imm..:

Qian, Kewen ; Fu, Wenyan ; Li, Tian...
Journal of Experimental & Clinical Cancer Research.  41 (2022)  1 - p. , 2022
 
1-15